Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2000 3
2004 1
2005 7
2006 1
2007 4
2008 8
2009 7
2010 12
2011 11
2012 12
2013 7
2014 5
2015 7
2016 5
2017 13
2018 15
2019 14
2020 11
2021 10
2022 5
2023 5
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).
Stemler J, Yeghiazaryan L, Stephan C, Mohn KG, Carcas-Sansuan AJ, Rodriguez ER, Moltó J, Mitxeltorena IV, Welte T, Zablockienė B, Akova M, Bethe U, Heringer S, Salmanton-García J, Jeck J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA; EU-COVAT-1 AGED study group on behalf of the VACCELERATE consortium. Stemler J, et al. Among authors: zarrouk m. Int J Infect Dis. 2024 Sep;146:107161. doi: 10.1016/j.ijid.2024.107161. Epub 2024 Jul 9. Int J Infect Dis. 2024. PMID: 38992789 Free article. Clinical Trial.
[Isoniazid-induced myopathy].
Chaouch N, Mejid M, Zarrouk M, Racil H, Rouhou SC, El Euch G, Chabbou A. Chaouch N, et al. Among authors: zarrouk m. Rev Pneumol Clin. 2011 Dec;67(6):354-8. doi: 10.1016/j.pneumo.2010.05.001. Epub 2010 Dec 3. Rev Pneumol Clin. 2011. PMID: 22137279 French.
[Erasmus' syndrome with pseudo-tumour masses].
Chaouch N, Mjid M, Zarrouk M, Rouhou SC, Ammous I, Hantous S, Racil H, Chabbou A. Chaouch N, et al. Among authors: zarrouk m. Rev Mal Respir. 2011 Sep;28(7):924-7. doi: 10.1016/j.rmr.2011.06.003. Epub 2011 Jul 23. Rev Mal Respir. 2011. PMID: 21943540 Review. French.
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).
Neuhann JM, Stemler J, Carcas AJ, Frías-Iniesta J, Akova M, Bethe U, Heringer S, Salmanton-García J, Tischmann L, Zarrouk M, Cüppers A, Grothe J, Leon AG, Mallon P, Negi R, Gaillard C, Saini G, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Yeghiazaryan L, Posch M, Koehler P, Cornely OA. Neuhann JM, et al. Among authors: zarrouk m. Vaccine. 2023 Nov 22;41(48):7166-7175. doi: 10.1016/j.vaccine.2023.10.029. Epub 2023 Oct 31. Vaccine. 2023. PMID: 37919141 Free article. Clinical Trial.
143 results